Company: TELO
Filing Date: 2025-11-10
Form Type: 10-Q
Source: 0001493152-25-021496
Chunk: 85

Company: Telomir Pharmaceuticals, Inc.
Filing Date: 2025-11-10
Form: 10-Q
Item: Item 3
Chunk 85
---
 no changes in our internal control over financial reporting, as such term is defined in Rules 13a-15(f) and 15d-15(f) of the Exchange
Act, during our third quarter of 2025 that materially affected, or are reasonably likely to materially affect, our internal control over
financial reporting.

19

CAUTIONARY
NOTE ON FORWARD-LOOKING STATEMENTS

This
Quarterly Report on Form 10-Q contains forward-looking statements. In some cases, you can identify forward-looking statements by terms
such as “may,” “will,” “should,” “expect,” “plan,” “anticipate,”
“could,” “intend,” “target,” “project,” “contemplate,” “believe,”
“estimate,” “predict,” “potential”, or “continue” or the negative of these terms or other
similar expressions. In particular, statements about the markets in which we operate, including growth of our various markets, and our
expectations, beliefs, plans, strategies, objectives, prospects, assumptions, or future events or performance contained in this quarterly
report under the headings “Risk Factors,” “Management’s Discussion and Analysis of Financial Condition and Results
of Operations” and “Business” are forward-looking statements. We have based these forward-looking statements on our
current expectations, assumptions, estimates and projections. While we believe these expectations, assumptions, estimates, and projections
are reasonable, such forward-looking statements are only predictions and involve known and unknown risks and uncertainties, many of which
are beyond our control. These and other important factors, including those discussed in this quarterly report under the headings “Risk
Factors,” “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and “Business,”
may cause our actual results, performance, or achievements to differ materially from any future results, performance or achievements
expressed or implied by these forward-looking statements, or could affect our share price. Important factors that could cause actual
results or events to differ materially from those expressed in forward-looking statements include, but are not limited to, the following:

●
our use of the net proceeds from our recent offering;

●
our ability to obtain and maintain regulatory approval of our product candidates;

●
our ability to successfully commercialize and market our product candidates, if approved;

●
our ability to contract with third-party suppliers, manufacturers and other service providers and their ability to perform adequately;

●
the potential market size, opportunity, and growth potential for our product candidates